http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5650389-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_078bbe737e97514e73c5aec6eb4f19a6 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4725 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 1993-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1997-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4393844843c7864ba05ec64ede30eef6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2f5578727be7bb1b55f1c42501e2fc3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_497ce3ec72a8a0833162cd2cbdb4f0a4 |
| publicationDate | 1997-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5650389-A |
| titleOfInvention | Methods for the inhibition of complement activation |
| abstract | Decorin, a small collagen-binding dermatan sulfate proteoglycan, is widely distributed as a component of extracellular matrices. Using a solid phase binding assay, the inventors demonstrated that decorin bound C1q at physiologic pH and ionic strength. The interaction did not require divalent cations and was time and temperature dependent reaching equilibrium in 4 hours at 37° C. Binding was specific and saturable with an apparent dissociation constant of 7.6×10 -9 M. Decorin was shown to bind pepsin-derived fragments containing the collagenous domain of C1q and collagenase-derived fragments containing the globular domain of C1q. Since these fragments share a short sequence of amino acids, this finding suggests that decorin binds to a region of C1q located near the junction of the two domains. Competition studies using purified preparations of the decorin core protein and the glycosaminoglycan chains showed that only the former inhibited binding of decorin to C1q indicating that the interaction is mediated by the decorin core protein. Decorin was shown to inhibit the hemolytic activity of purified C1 as well as C1 in normal human serum. Approximately 50% inhibition was observed at a decorin concentration of 2 μg/ml. Inhibition was not observed if C1 was bound to antigen-complexed antibody. Furthermore, neither the core protein, nor the glycosaminoglycan chain of decorin inhibited C1 indicating that the intact proteoglycan is necessary for functional activity. These studies therefore demonstrate the usefulness of decorin and related proteoglycans in suppression of complement activation of the immune system. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004112861-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004112861-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007112406-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007123466-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010087362-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011195106-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004259787-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7838021-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6413931-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9393351-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0068264-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2856305-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0068264-A2 |
| priorityDate | 1993-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 532.